- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04791137
Feasibility Randomized Controlled Trial Using a 'Leapfrog' Design
January 27, 2022 updated by: Simon Blackwell, Ruhr University of Bochum
Feasibility Randomized Controlled Trial Using a 'Leapfrog' Design: Optimizing an Internet-delivered Cognitive Training Intervention to Reduce Anhedonia
This study is a small-scale randomized controlled trial (RCT) using a 'Leapfrog' design (Blackwell, Woud, Margraf, & Schönbrodt, 2019) with the aim of investigating feasibility of this design in the context of an RCT of an internet-delivered intervention.
The leapfrog design will be applied to a simple cognitive training intervention, imagery cognitive bias modification (imagery CBM), completed over a four-week training period.
The trial will start with the three arms described in the initial registration, but these will be removed and new arms added over the course of the trial on the basis of sequential Bayesian analyses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
188
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Nordrhein-Westfalen
-
Bochum, Nordrhein-Westfalen, Germany, 44801
- Ruhr University of Bochum
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Aged 18 or over
- Fluent German
- Willing and able to complete all study procedures (including having a suitable device/ internet access)
- Interested in monitoring their mood over the study time-period (one month)
- Score of ≥ 6 on the Quick Inventory of Depressive Symptomatology, including ≥ 1 on item 13 (General Interest), indicating at least mild levels of depression symptoms and anhedonia
Exclusion Criteria:
- No exclusion criteria set
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Monitoring
Participants complete weekly questionnaires (QIDS-SR, PMH, GAD-7) on a weekly basis but receive no intervention.
|
|
Experimental: Standard imagery cognitive bias modification
Participants are scheduled to complete a first introductory session then 12 further training sessions of a 'standard' imagery cognitive bias modification (CBM) intervention derived from that implemented in previous studies.
|
The imagery cognitive bias modification intervention is derived from that developed via experimental psychopathology research (e.g.
Holmes et al., 2009) and adapted for clinical applications in the context of depression (e.g.
Blackwell & Holmes, 2010; Blackwell et al., 2015).
The intervention is a series of training sessions in which participants listen to training scenarios consisting of descriptions of everyday situations, structured so that they start ambiguously but always end positively.
Participants are instructed to imagine themselves in the situations described as the scenarios unfold.
It is hypothesised that via repeatedly practising imagining positive resolutions for ambiguous situations in the training sessions, a bias is trained to automatically imagine positive resolutions for ambiguous situations encountered in daily life.
|
Experimental: Standard imagery cognitive bias modification plus additional rationale and transfer instructions
Participants are scheduled to complete a first introductory session then 12 further training sessions of a 'standard' imagery cognitive bias modification (CBM) intervention, but in addition are first presented with a more extended rationale for completing the training, and during each training session are provided with instructions to practice retrieval and rehearsal of the training contents in between sessions.
|
The imagery cognitive bias modification intervention is derived from that developed via experimental psychopathology research (e.g.
Holmes et al., 2009) and adapted for clinical applications in the context of depression (e.g.
Blackwell & Holmes, 2010; Blackwell et al., 2015).
The intervention is a series of training sessions in which participants listen to training scenarios consisting of descriptions of everyday situations, structured so that they start ambiguously but always end positively.
Participants are instructed to imagine themselves in the situations described as the scenarios unfold.
It is hypothesised that via repeatedly practising imagining positive resolutions for ambiguous situations in the training sessions, a bias is trained to automatically imagine positive resolutions for ambiguous situations encountered in daily life.
|
Experimental: Standard imagery cognitive bias modification with frequent brief sessions
Participants are scheduled to complete a first introductory session then 40 brief (~5 min) sessions of a 'standard' imagery cognitive bias modification (CBM) intervention, with 2 per day five days per week for each of the four training weeks.
In addition, as with the arm "Standard imagery cognitive bias modification plus additional rationale and transfer instructions", participants are first presented with a more extended rationale for completing the training, and during many of the training sessions are provided with instructions to practice retrieval and rehearsal of the training contents in between sessions.
This arm was added into the ongoing trial on 30.05.21.
|
The imagery cognitive bias modification intervention is derived from that developed via experimental psychopathology research (e.g.
Holmes et al., 2009) and adapted for clinical applications in the context of depression (e.g.
Blackwell & Holmes, 2010; Blackwell et al., 2015).
The intervention is a series of training sessions in which participants listen to training scenarios consisting of descriptions of everyday situations, structured so that they start ambiguously but always end positively.
Participants are instructed to imagine themselves in the situations described as the scenarios unfold.
It is hypothesised that via repeatedly practising imagining positive resolutions for ambiguous situations in the training sessions, a bias is trained to automatically imagine positive resolutions for ambiguous situations encountered in daily life.
|
Experimental: Standard imagery cognitive bias modification with a less intensive schedule
Participants are scheduled to complete a first introductory session then 11 further sessions of a 'standard' imagery cognitive bias modification (CBM) intervention, with 3 sessions scheduled for each of the four training weeks.
Sessions have fewer training scenarios than the "Standard imagery cognitive bias modification" condition and more varied task instructions.
In addition, as with the arm "Standard imagery cognitive bias modification plus additional rationale and transfer instructions", participants are first presented with a more extended rationale for completing the training, and during many of the training sessions are provided with instructions to practice retrieval and rehearsal of the training contents in between sessions.
This arm was added into the ongoing trial on 09.06.21.
|
The imagery cognitive bias modification intervention is derived from that developed via experimental psychopathology research (e.g.
Holmes et al., 2009) and adapted for clinical applications in the context of depression (e.g.
Blackwell & Holmes, 2010; Blackwell et al., 2015).
The intervention is a series of training sessions in which participants listen to training scenarios consisting of descriptions of everyday situations, structured so that they start ambiguously but always end positively.
Participants are instructed to imagine themselves in the situations described as the scenarios unfold.
It is hypothesised that via repeatedly practising imagining positive resolutions for ambiguous situations in the training sessions, a bias is trained to automatically imagine positive resolutions for ambiguous situations encountered in daily life.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dimensional Anhedonia Rating Scale (DARS)
Time Frame: Post-intervention (4 weeks post-baseline).
|
A 17-item scale measuring anhedonia (Rizvi et al., 2015).
The primary analysis is a between-groups comparison of post-intervention scores, controlling for baseline scores, using constrained longitudinal data analysis (cLDA).
An approximate Bayes factor is then calculated via the t-statistic for the Time x Group effect with a directional default Cauchy prior (rscale parameter = √2/2).
|
Post-intervention (4 weeks post-baseline).
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quick Inventory of Depressive Symptomatology - Self Report (QIDS)
Time Frame: Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline)
|
A 15-item version of the QIDS (Rush et al., 2013), excluding the suicidal ideation item, will be used
|
Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline)
|
GAD-7
Time Frame: Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline)
|
A brief 7-item measure of generalized anxiety symptoms (Spitzer et al., 2006)
|
Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline)
|
Positive Mental Health Scale (PMH)
Time Frame: Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline)
|
A 9-item questionnaire designed to assess positive mental health (Lukat et al., 2016)
|
Baseline, 1 week post-baseline, 2 weeks post-baseline, 3 weeks post-baseline, post-intervention (4 weeks post-baseline)
|
Ambiguous Scenarios Test for Depression (AST)
Time Frame: Baseline and post-intervention (4 weeks post-baseline)
|
A measure with two 15-item parallel forms designed to assess depression-relevant negative interpretation biases (Rochbacher & Reinecke, 2014)
|
Baseline and post-intervention (4 weeks post-baseline)
|
Prospective Imagery Test (PIT)
Time Frame: Baseline and post-intervention (4 weeks post-baseline)
|
A measure designed to assess vividness of positive and negative future-oriented imagery (Stöber et al., 2000), here administered with as two 10-item parallel versions (each with 5 positive and 5 negative items).
|
Baseline and post-intervention (4 weeks post-baseline)
|
Negative Effects Questionnaire - Short Form (NEQ)
Time Frame: Post-intervention (4 weeks post-baseline)
|
A 20-item questionnaire designed to assess potential negative effects of psychological interventions (Rozental et al., 2019)
|
Post-intervention (4 weeks post-baseline)
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Spontaneous Use of Imagery Scale (SUIS)
Time Frame: Baseline
|
A 12-item questionnaire assessing experience of spontaneous non-emotional mental imagery in daily life (Reisberg et al., 2003)
|
Baseline
|
Credibility / Expectancy Questionnaire (CEQ)
Time Frame: Baseline
|
A 6-item questionnaire assessing participants' evaluation of the credibility of an intervention (3 items) and their expectancy of symptom improvement (3 items) over the course of an intervention (Devilly & Borkovec, 2000)
|
Baseline
|
Feedback questionnaire
Time Frame: Post-intervention (4 weeks post-baseline)
|
A questionnaire containing both rating scales and open questions for eliciting participants' feedback about the study and interventions completed (if applicable)
|
Post-intervention (4 weeks post-baseline)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Blackwell, S. E., Woud, M. L., Margraf, J., & Schönbrodt, F. D. (2019). Introducing the leapfrog design: A simple Bayesian adaptive rolling trial design for accelerated treatment development and optimization. Clinical Psychological Science, 7, 1222-1243. https://doi.org/10.1177/2167702619858071
- Blackwell SE, Schonbrodt FD, Woud ML, Wannemuller A, Bektas B, Braun Rodrigues M, Hirdes J, Stumpp M, Margraf J. Demonstration of a 'leapfrog' randomized controlled trial as a method to accelerate the development and optimization of psychological interventions. Psychol Med. 2022 Nov 4:1-11. doi: 10.1017/S0033291722003294. Online ahead of print.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 9, 2021
Primary Completion (Actual)
January 11, 2022
Study Completion (Actual)
January 11, 2022
Study Registration Dates
First Submitted
March 8, 2021
First Submitted That Met QC Criteria
March 8, 2021
First Posted (Actual)
March 10, 2021
Study Record Updates
Last Update Posted (Actual)
January 28, 2022
Last Update Submitted That Met QC Criteria
January 27, 2022
Last Verified
January 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 365
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Anonymised data will be made available on publication via a suitable repository such as the Open Science Framework, and will be made available to reviewers at the time of submission (or publically with a pre-print version of the manuscript).
Data made available will be the research data reported in the publication, with the exception of any data that could compromise participant anonymity.
IPD Sharing Time Frame
Supporting information will be made available on publication via a suitable repository such as the Open Science Framework, and will be made available to reviewers at the time of submission (or publically with a pre-print version of the manuscript).
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- ICF
- ANALYTIC_CODE
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Depression
-
ProgenaBiomeRecruitingDepression | Depression, Postpartum | Depression, Anxiety | Depression Moderate | Depression Severe | Clinical Depression | Depression in Remission | Depression, Endogenous | Depression ChronicUnited States
-
Washington University School of MedicineCompletedTreatment Resistant Depression | Late Life Depression | Geriatric Depression | Refractory Depression | Therapy-Resistant DepressionUnited States, Canada
-
Kintsugi Mindful Wellness, Inc.Sonar Strategies; Vituity PsychiatryRecruitingDepression | Depression Moderate | Depression Severe | Depression MildUnited States
-
University of California, San FranciscoRecruitingDepression Moderate | Depression Mild | Depression, TeenUnited States
-
University GhentUniversiteit Antwerpen; Janssen-Cilag Ltd.RecruitingDepression Moderate | Depression Severe | Depression MildBelgium
-
Baylor College of MedicineUniversity of TexasRecruitingDepression | Depression Moderate | Depression Severe | Suicide and Self-harm | Depression in Adolescence | Depression MildUnited States
-
University of Cape TownNational Institute of Mental Health (NIMH)CompletedPostpartum Depression | Clinical Depression | Moderate DepressionSouth Africa
-
Lawson Health Research InstituteTerminated
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; National Institute of Mental...CompletedMajor Depressive Disorder | Treatment Resistant Depression | Treatment-Refractory Depression | Late Life Depression | Geriatric DepressionUnited States, Canada
-
Northern Illinois UniversityUniversity Autonoma de Santo DomingoTerminatedDepression Moderate | Depression MildUnited States, Dominican Republic
Clinical Trials on Imagery cognitive bias modification
-
Ryerson UniversityMinistry of Research, Innovation and Science, OntarioSuspended
-
Ruhr University of BochumCompleted
-
University of VirginiaCompleted
-
Istanbul Sabahattin Zaim UniversityCompletedPerfectionism | Intolerance to UncertaintyUnited States
-
Temple UniversityNot yet recruiting
-
Universidad Complutense de MadridCompletedDepression | Cognitive ChangeSpain
-
Centre for Addiction and Mental HealthAmerican Foundation for Suicide PreventionCompletedSubstance DependenceCanada
-
University of SouthamptonEconomic and Social Research Council, United KingdomCompletedChronic Pain | Musculoskeletal Pain DisorderUnited Kingdom
-
King's College LondonSouth London and Maudsley NHS Foundation Trust; South West London and St George... and other collaboratorsUnknownEating Disorders in AdolescenceUnited Kingdom
-
Dokuz Eylul UniversityThe Scientific and Technological Research Council of TurkeyCompletedObsessive-compulsive Disorders and Symptoms | Obsessive Thoughts | Obsessive Compulsive BehaviorTurkey